Literature DB >> 20675272

Age of menarche in girls with cystic fibrosis.

Wioleta Umławska1, Dorota Sands, Anna Zielińska.   

Abstract

UNLABELLED: Malnutrition, delayed growth and puberty are commonly observed in children suffering from cystic fibrosis. The aim of this study was to assess the age of menarche in girls with CF using status quo analysis. The relationship between types of CFTR mutations and onset of the first menstruation was also evaluated. Material was based on somatic data gathered from medical history records of 47 girls with cystic fibrosis, aged 11-18 years. All girls were patients of the Mother and Child Institute in Warsaw (Poland).
RESULTS: The age of menarche in the girls in the study group was 14.65+/-1.21 years. In comparison with the healthy child population, girls with cystic fibrosis experienced menarche with 2 years' delay. Menstruating girls were found to be statistically older and taller than their non-menstruating consorts. Regarding body mass and BMI, a marked tendency towards higher parameter values was noted in the menstruating group, although the differences did not reach statistical significance. A significant relationship between onset of menarche and type of CFTR mutation was found. Girls with cystic fibrosis enter puberty later than their peers, in spite of intensive medical care. The issue of growth and puberty in children with CF requires further detailed investigation under clinical and auxological aspects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20675272     DOI: 10.2478/v10042-010-0051-x

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  8 in total

1.  Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor.

Authors:  Michael S Stalvey; Jesse Pace; Minoo Niknian; Mark N Higgins; Valerie Tarn; Joy Davis; Sonya L Heltshe; Steven M Rowe
Journal:  Pediatrics       Date:  2017-02       Impact factor: 7.124

2.  Menarche in pediatric patients with Crohn's disease.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Eric Vittinghoff
Journal:  Dig Dis Sci       Date:  2012-06-29       Impact factor: 3.199

3.  Relationship Between Estrogen Treatment and Skeletal Health in Women With Cystic Fibrosis.

Authors:  Malinda Wu; Erika L Bettermann; Neha Arora; William R Hunt; Courtney McCracken; Vin Tangpricha
Journal:  Am J Med Sci       Date:  2020-06-06       Impact factor: 2.378

Review 4.  Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Authors:  Oranan Siwamogsatham; Jessica A Alvarez; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

5.  A cross-sectional study of growth, nutritional status and body proportions in children and adolescents at a medical center specializing in the treatment of cystic fibrosis in Poland.

Authors:  Dorota Sands; Wioleta Umławska; Anna Zielińska
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

6.  Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density.

Authors:  Malinda Wu; William R Hunt; Melissa S Putman; Vin Tangpricha
Journal:  J Clin Transl Endocrinol       Date:  2020-03-19

7.  Triage for Malnutrition Risk among Pediatric and Adolescent Outpatients with Cystic Fibrosis, Using a Disease-Specific Tool.

Authors:  Dimitrios Poulimeneas; Maria G Grammatikopoulou; Argyri Petrocheilou; Athanasios G Kaditis; Tonia Vassilakou
Journal:  Children (Basel)       Date:  2020-12-04

8.  Use of estrogen supplementation is associated with higher quality of life scores in women with cystic fibrosis.

Authors:  Malinda Wu; Neha Arora; Viranuj Sueblinvong; William R Hunt; Vin Tangpricha
Journal:  J Clin Transl Endocrinol       Date:  2021-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.